Experimental carcinogenesis of antitumour drugs.
D000477:Alkylating Agents / Q000009:adverse effects; D000818:Animals; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D002273:Carcinogens; D004305:Dose-Response Relationship, Drug; D000882:Haplorhini; D007942:Leukemia, Experimental / Q000139:chemically induced; D051379:Mice; D009374:Neoplasms, Experimental / Q000139:chemically induced*; D051381:Rats; D012306:Risk
D000477:Alkylating Agents; D000970:Antineoplastic Agents; D002273:Carcinogens